Jinhui Xue

机构：Zhengzhou Central Hospital

发表论文 32 篇 · 总被引 605 次 · h-index 12

代表论文

• BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study (2024 · The Lancet Oncology · 被引 131)
• Fecal Signatures of Streptococcus anginosus and Streptococcus constellatus for Noninvasive Screening and Early Warning of Gastric Cancer (2022 · Gastroenterology · 被引 109)
• A B7H3-targeting antibody–drug conjugate in advanced solid tumors: a phase 1/1b trial (2025 · Nature Medicine · 被引 88)
• The Pan-Immune-Inflammation Value predicts the survival of patients with anaplastic lymphoma kinase-positive non-small cell lung cancer treated with first-line ALK inhibitor (2022 · Translational Oncology · 被引 44)
• Comprehensive analysis of the HOXA gene family identifies HOXA13 as a novel oncogenic gene in kidney renal clear cell carcinoma (2020 · Journal of Cancer Research and Clinical Oncology · 被引 34)
• Passivation mechanism of Cu and Zn with the introduction of composite passivators during anaerobic digestion of pig manure (2022 · Bioresource Technology · 被引 31)